Why is Genpharmasec falling/rising?

As of 18-Sep, Genpharmasec Ltd's stock price is currently at 1.94, reflecting an increase of 0.03 or 1.57%. The stock has shown some positive movement today, outperforming its sector by 2.33%. Notably, the stock's delivery volume has risen by 19.82% compared to the 5-day average, indicating increased investor participation. However, despite this short-term gain, the stock has underperformed significantly over the past week, month, and year, with returns of -0.51%, -6.73%, and -42.94%, respectively. The company recently reported a substantial growth in operating profit of 2500% and net sales growth of 42.8%, but it also faces long-term challenges, including a weak ability to service debt and negative operating profits, which contribute to its overall risk profile.
In the broader market context, while Genpharmasec's stock has seen a slight uptick today, it has consistently underperformed against the benchmark, the Sensex, which has gained 1.80% over the past week and 2.14% over the past month. The stark contrast in performance is evident as the stock has generated a return of -42.94% over the past year, while the Sensex has remained relatively flat at +0.08%. This consistent underperformance against the benchmark, coupled with the company's weak long-term fundamentals, suggests that while there may be short-term gains, the overall outlook remains concerning for investors.